Already used in canines, the active ingredient Fortetropin will be used in a new feline formula based on research of safety and tolerability. A research-based nutrition company that serves both humans and animals, MYOS Corp, shared results from a recent poster presentation at the June American College of Veterinary Internal Medicine (ACVIM) Forum. The placebo-controlled study was conducted by researchers at the University of Florida College of Veterinary Medicine and found that the therapy was safe and well-tolerated by cats when administered between 1 gram/day (~200 mg/kg/day) to as high as 4 gram/day (~800 mg/kg/day) across two weeks.
Based on the findings, MYOS will launch its Feline Muscle Health Formula. According to the company, the formula will include the proprietary ingredient, Fortetropin, which has been effective at increasing the growth of muscle mass in dogs and humans. Loss of muscle mass due to age, a condition called sarcopenia, is an issue for elderly dogs and cats.
"I am optimistic that this product has the potential to be transformative for cats," said Albert Ahn, DVM, Chief Veterinary Adviser, MYOS CORP. "There are very few high-quality nutrition products on the market that address feline sarcopenia and are supported by results from clinical trials. In addition, because Fortetropin is an all-natural nutrition product, we expect it to be well received by feline practitioners, particularly those that belong to the Holistic Veterinary community."
List
Add
Please enter a comment